Judyann C. Olson, MD

Titles
Program director, Rheumatology, Children's Hospital of Wisconsin; associate professor, Pediatrics (Rheumatology), Medical College of Wisconsin.

Division
Rheumatology

Research interests
Rheumatological disorders

Study interests
Juvenile dermatomyositis, juvenile idiopathic arthritis.

Education
Medical degree, Loyola University of Chicago Stritch School of Medicine, 1979; residency, Medical College of Wisconsin, Milwaukee, 1980–1982; fellowship, Cincinnati Children's Hospital Medical Center, 1984–1986.

Certifications
National board, 1980; Pediatrics, 1984; Pediatric Rheumatology, 1992.

Honors
The Best Doctors in America, 1998, 2001, 2004.

Representative publications:

• Sheth AP, Olson JC, Esterly NB. Cutaneous Polyarteritis Nodosa of Childhood. Journal of the American Academy of Dermatology. 1994; 31:561-6.
• Zvulunov A, Olson JC, Carpenter D, Esterly N. Familial Scleroderma-like Deformity of the Fingers. Journal of the Amercian Academy of Dermatology. 1995; 33:302-305.
• Morrell DS, Challgren E, Nijhawan A, Olson J, Laumann A, Esterly NB. Two Cases for Diagnosis: Asymmetric Childhood Scleroderma or Stiff Skin Syndrome? Pediatric Dermatology. 2003; 20(4):350-55.
• Lovell DJ, Giannini EH, Reiff A, Jones O, Schneider R, Olsonm JC, Stein L, Gedalia A, Ilowite NT, Wallace CA, Burge DJ, Finck BK, Lange M for the Pediatric Rheumatology Collaborative Study Group. Long-term Efficacy and Safety of Etanercept in Children with Polyarticular-course Juvenile Rheumatoid Arthritis. Arthritis and Rheumatism. 2003; 48(1):218-226.
• Olson JC. Juvenile Idiopathic Arthritis: An Update. Wisconsin Medical Journal. 2003; 102(7):45-50.

Grants

• Psychosocial Factors, Quality of Life and Health Care Utilization in Juvenile Rheumatoid Arthritis, principal investigator, 95/110, HRRC 09-96, Children's Hospital and Health System Foundation, 7/1/96-6/30/02.
• Safety, Population Pharmacokinetics and Efficacy of Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (TNF:Fc) in Children with Juvenile Rheumatoid Arthritis, principal investigator, Children's Hospital of Wisconsin, 97/48, HRRC 174-97, Immunex Corporation, 7/1/97-5/31/98.
• Preserving Mobility of Juveline Rheumatoid Arthritis Children using Nocturnal TES, co-investigator, National Institutes of Health Grant #1 R29 A R4 5312-01, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 9/20/97-8/31/03, CDFA# 93.846.
• A Proposal to Enhance the Care and Treatment of Children with Juvenile Rheumatoid Arthritis and Related Diseases, principal investigator, Children's Hospital and Health System Foundation, 9/1/00-6/30/05.
• Registry of Biologic-response Modifier in Children with Juvenile Rheumatoid Arthritis, principal investigator, 6/1/01-5/31/05.
• Double-blind Randomized Placebo-controlled Study Comparing COX-2 Inhibitor in NSAID Children with Juvenile Rheumatoid Arthritis, co-investigator, 9/15/01–9/15/03.
• Genetics of Pediatric-onset Systemic Lupus Erythematosus, co-investigator, NIH IR01 AR45650, subcontract #H15990, subcontract from Children's Memorial Hospital, Chicago, awarded to James Nocton, MD, 8/2000–12/2005.
• Gene Expression in Pediatric Arthritis, co-investigator, NIH, subcontract from Cincinnati Children's Hospital, Ohio, awarded to Judyann Olson, MD, 7/1/2003–6/30/2008.
• Clinical Protocol for a Randomized, Double-blind, Multicenter, Active-controlled Parallel Group Study to Evaluate the Efficacy and Safety of COX-2 Inhibitor Compared to NSAID Suspension in Patients with JRA, co-investigator, 4/2003–4/2005.

Contact
Children's Research Institute
8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 266-6700
Fax: (414) 266-6695
E-mail: jcolson@mcw.edu